Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Eagle Pharmaceuticals Inc | EGRX | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 3.47 | 03:05:39 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 3.47 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 3.2101 - 23.52 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 3.47 | USD |
Eagle Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 45.06M | 12.99M | - | 316.61M | 35.64M | 2.74 | 1.26 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Eagle Pharmaceuticals News
| Date | Time | Source | News Article |
|---|---|---|---|
| 5/29/2024 | 07:20 | Edgar (US Regulatory) | Form 8-K - Current report |
| 5/22/2024 | 08:08 | Edgar (US Regulatory) | Form 8-K - Current report |
| 5/15/2024 | 08:29 | Edgar (US Regulatory) | Form 8-K - Current report |
| 5/10/2024 | 16:27 | Edgar (US Regulatory) | Form NT 10-Q - Notification of inability to timely file Form.. |
| 3/08/2024 | 15:49 | Edgar (US Regulatory) | Form 8-K - Current report |
| 3/01/2024 | 15:40 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 3/01/2024 | 06:35 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/29/2024 | 19:23 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 2/29/2024 | 15:44 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 2/29/2024 | 07:09 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/14/2024 | 16:09 | Edgar (US Regulatory) | Form SC 13D - General statement of acquisition of beneficial.. |
| 2/13/2024 | 14:53 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical EGRX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.78 | 3.93 | 3.2101 | 3.46 | 184,498 | -0.31 | -8.20% |
| 1 Month | 4.47 | 4.98 | 3.2101 | 4.03 | 162,568 | -1.00 | -22.37% |
| 3 Months | 6.06 | 6.20 | 3.2101 | 4.63 | 152,300 | -2.59 | -42.74% |
| 6 Months | 5.99 | 6.81 | 3.2101 | 5.05 | 212,605 | -2.52 | -42.07% |
| 1 Year | 19.51 | 23.52 | 3.2101 | 9.88 | 192,391 | -16.04 | -82.21% |
| 3 Years | 36.62 | 58.25 | 3.2101 | 27.03 | 154,968 | -33.15 | -90.52% |
| 5 Years | 50.93 | 64.94 | 3.2101 | 35.66 | 150,827 | -47.46 | -93.19% |
Eagle Pharmaceuticals Description
| Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. The company develops and commercializes injectable products in the areas of critical care, orphan diseases, and oncology. Its product portfolio consists of four approved products: Argatroban, Ryanodex, Belrapzo, and Bendeka. The company currently has multiple product candidates in advanced stages of development and is under review for approval by the Food and Drug Administration. |
